3Hall M, Krupp P, Monka C, et al. Safety of oral terbinafine: results of a postmarketing surveillance study in 25 884 patients[J]. Arch Dermotol, 1997, 33(10) : 1213- 1219.
4Bong JL, Lucke TW, Evans CD. Persistent impairment of taste resulting from terbinafine[ J]. B J Dermatol, 1998, 139(4) :747-748.
5Stricker BH, Van Riemsdijk MM, Sturkenboom MC, et al. Taste loss to terbinafine: a case-control study of potential risk factors[J]. Br J Clin Pharmacol, 1996, 42 (3) : 313-318.
6Duxbury A J, Oliver R J, Pemberton MN. Persistent impairment of taste associated with terbinafine. BDJ, 2000, 188(5) :295-296.
7Beutler M, Hartmann K, Kuhn M, et al. Taste disorders and terbinafine. BMJ, 1993, 307 (6895) :26.
8O'Sullivan DP, Needham CA, Bangs A, et al. Postmarketing surveillance of oral terbinafine in the UK: report of a large cohort study[J]. Br J Clin Pharmacol, 1996, 42(5): 559-565.
9Stricker BH, de Jong PA, Schreuder F, et al, Loss of taste sensation in terbinafine administration [J]. Ned Tijdschr Geneeskd, 1992, 136(49): 2438-2440.
10Stricker BH, Van Riemsdijk MM, Sturkenboom MC, et al. Taste loss to terbinafine: a case-control study of potential risk factors [J]. Br J Clin Pharmacol, 1996, 42(3): 313-318.
